Biocept Announces Clinical Validation and Commercial Launch of its Target Selector(TM) Multi-Gene Liquid Biopsy Panel for Lung Cancer

Stock Information for Biocept Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biocept Inc.

Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally
Biocept Reports First Quarter 2019 Financial Results
Biocept to Release First Quarter 2019 Financial Results and Host Investor Conference Call on May 8, 2019
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results
Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment
Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019
Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.